W S Aronow

Summary

Publications

  1. request reprint
    Aronow W. Drug treatment of peripheral arterial disease in the elderly. Drugs Aging. 2006;23:1-12 pubmed
    ..In addition, medical therapy may result in significant improvements in walking ability that may obviate the need for lower extremity angioplasty with stenting and bypass surgery. ..
  2. Aronow W. Office management of hypertension in older persons. Am J Med. 2011;124:498-500 pubmed publisher
    ..If the blood pressure is more than 20/10 mm Hg above the goal blood pressure, drug therapy should be initiated with 2 antihypertensive drugs. Other coronary risk factors must be treated. ..
  3. Gupta T, Kolte D, Khera S, Harikrishnan P, Mujib M, Aronow W, et al. Smoker's Paradox in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. J Am Heart Assoc. 2016;5: pubmed publisher
    ....
  4. Gupta T, Kolte D, Mohananey D, Khera S, Goel K, Mondal P, et al. Relation of Obesity to Survival After In-Hospital Cardiac Arrest. Am J Cardiol. 2016;118:662-7 pubmed publisher
    ..In conclusion, this large retrospective analysis of a nationwide cohort of patients with IHCA demonstrated higher risk-adjusted odds of survival in obese patients, consistent with an "obesity paradox." ..
  5. Aronow W. Treatment of Heart Failure with Abnormal Left Ventricular Systolic Function in Older Adults. Heart Fail Clin. 2017;13:467-483 pubmed publisher
    ..Exercise training is recommended. Indications for implantable cardioverter-defibrillator and cardiac resynchronization therapy are discussed. ..
  6. Aronow W. Heart Failure Complicating Acute Mtyocardial Infarction. Heart Fail Clin. 2017;13:513-525 pubmed publisher
    ....
  7. Dooley D, Lam P, Ahmed A, Aronow W. The Role of Positive Inotropic Drugs in the Treatment of Older Adults with Heart Failure and Reduced Ejection Fraction. Heart Fail Clin. 2017;13:527-534 pubmed publisher
    ..However, recommendations from national heart failure guidelines may be generalized to older HFrEF patients on an individual basis, taking into consideration the basic geriatric principles of pharmacotherapy: start low and go slow. ..
  8. Jacobson J, Iwai S, Aronow W. Treatment of Ventricular Arrhythmias and Use of Implantable Cardioverter-Defibrillators to Improve Survival in Older Adult Patients with Cardiac Disease. Heart Fail Clin. 2017;13:589-605 pubmed publisher
    ..The value of implantable cardiac defibrillators (ICDs) may be influenced by patient age. This article discusses long-term treatment of VA and the use of ICDs in the elderly. ..
  9. request reprint
    Aronow W. Management of peripheral arterial disease. Cardiol Rev. 2005;13:61-8 pubmed
    ..However, amputation should be performed if tissue loss has progressed beyond the point of salvage, if surgery is too risky, if life expectancy is very low, or if functional limitations diminish the benefit of limb salvage. ..
  10. Aronow W. Office management of peripheral arterial disease. Am J Med. 2010;123:790-2 pubmed publisher
    ....

Detail Information

Publications13

  1. request reprint
    Aronow W. Drug treatment of peripheral arterial disease in the elderly. Drugs Aging. 2006;23:1-12 pubmed
    ..In addition, medical therapy may result in significant improvements in walking ability that may obviate the need for lower extremity angioplasty with stenting and bypass surgery. ..
  2. Aronow W. Office management of hypertension in older persons. Am J Med. 2011;124:498-500 pubmed publisher
    ..If the blood pressure is more than 20/10 mm Hg above the goal blood pressure, drug therapy should be initiated with 2 antihypertensive drugs. Other coronary risk factors must be treated. ..
  3. Gupta T, Kolte D, Khera S, Harikrishnan P, Mujib M, Aronow W, et al. Smoker's Paradox in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. J Am Heart Assoc. 2016;5: pubmed publisher
    ....
  4. Gupta T, Kolte D, Mohananey D, Khera S, Goel K, Mondal P, et al. Relation of Obesity to Survival After In-Hospital Cardiac Arrest. Am J Cardiol. 2016;118:662-7 pubmed publisher
    ..In conclusion, this large retrospective analysis of a nationwide cohort of patients with IHCA demonstrated higher risk-adjusted odds of survival in obese patients, consistent with an "obesity paradox." ..
  5. Aronow W. Treatment of Heart Failure with Abnormal Left Ventricular Systolic Function in Older Adults. Heart Fail Clin. 2017;13:467-483 pubmed publisher
    ..Exercise training is recommended. Indications for implantable cardioverter-defibrillator and cardiac resynchronization therapy are discussed. ..
  6. Aronow W. Heart Failure Complicating Acute Mtyocardial Infarction. Heart Fail Clin. 2017;13:513-525 pubmed publisher
    ....
  7. Dooley D, Lam P, Ahmed A, Aronow W. The Role of Positive Inotropic Drugs in the Treatment of Older Adults with Heart Failure and Reduced Ejection Fraction. Heart Fail Clin. 2017;13:527-534 pubmed publisher
    ..However, recommendations from national heart failure guidelines may be generalized to older HFrEF patients on an individual basis, taking into consideration the basic geriatric principles of pharmacotherapy: start low and go slow. ..
  8. Jacobson J, Iwai S, Aronow W. Treatment of Ventricular Arrhythmias and Use of Implantable Cardioverter-Defibrillators to Improve Survival in Older Adult Patients with Cardiac Disease. Heart Fail Clin. 2017;13:589-605 pubmed publisher
    ..The value of implantable cardiac defibrillators (ICDs) may be influenced by patient age. This article discusses long-term treatment of VA and the use of ICDs in the elderly. ..
  9. request reprint
    Aronow W. Management of peripheral arterial disease. Cardiol Rev. 2005;13:61-8 pubmed
    ..However, amputation should be performed if tissue loss has progressed beyond the point of salvage, if surgery is too risky, if life expectancy is very low, or if functional limitations diminish the benefit of limb salvage. ..
  10. Aronow W. Office management of peripheral arterial disease. Am J Med. 2010;123:790-2 pubmed publisher
    ....
  11. Palaniswamy C, Frishman W, Aronow W. Carcinoid heart disease. Cardiol Rev. 2012;20:167-76 pubmed publisher
    ....
  12. Aronow W. Managing Hypertension in the Elderly: What is Different, What is the Same?. Curr Hypertens Rep. 2017;19:67 pubmed publisher
    ..The incidence of serious adverse events was similar in both treatment groups. The SPRINT trial provides very important information on the efficacy and safety of lowering the SBP to <120 mmHg in elderly adults with hypertension. ..
  13. Rochlani Y, Khan M, Aronow W. Managing Hypertension in Patients Aged 75 Years and Older. Curr Hypertens Rep. 2017;19:88 pubmed publisher
    ..The initial drug of choice for the treatment of hypertension in adults aged 75 years and older should be based on co-morbidities, co-incidental indications, tolerability, and cost. ..